Breckenridge Announces Tentative Approval of its ANDA for Dabigatran Etexilate Capsules (generic for Pradaxa®)

/PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted tentative approval of its Abbreviated...

Related Keywords

Japan ,Towa ,Yamaguchi ,Berlin ,Germany ,Robert Gasparino ,Drug Administration ,Breckenridge Pharmaceutical Inc ,Business Development ,Breckenridge Pharmaceutical ,Abbreviated New Drug Application ,Dabigatran Etexilate Capsules ,Towa Pharmaceutical Europe ,Towa Pharmaceutical ,Associate Vice President ,Nc ,